Mannkind reported $-14432000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Halozyme Therapeutics HALO:US USD 73.71M 21.78M
Immunogen IMGN:US USD -77755000 15.73M
Insmed INSM:US USD -130773000 35.63M
Karyopharm Therapeutics KPTI:US USD -36279000 12.66M
Macrogenics MGNX:US USD -24813000 16.49M
Mannkind MNKD:US USD -14432000 14.59M
Minerva Neurosciences NERV:US USD -6901000 1.82M
Novavax NVAX:US USD -166141000 342.93M
Peregrine Pharmaceuticals PPHM:US USD 2.27M 1.68M
Pfizer PFE:US USD 10.67B 3.11B
Xencor XNCR:US USD -31671000 2.3M